Add Popular Science (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Get the Popular ...

A new meningitis vaccine tested in two African countries has shown promise in the fight against the disease, eliciting immune responses against five main strains. A new study published by the New ...

Please provide your email address to receive an email when new articles are posted on . A pentavalent vaccine against meningitis continued to show promise in a phase 3 trial in Africa’s meningitis ...

Dr. Samba O. Sow, Director General of CVD-Mali, has led efforts to eradicate meningococcal disease in the African Meningitis Belt for more than a decade. University of Maryland School of Medicine ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

University of Maryland School of Medicine (UMSOM) researchers, as part of the Infectious Diseases Clinical Research Consortium (IDCRC), provided an interim analysis showing that the pentavalent ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. An investigational pentavalent vaccine for Neisseria ...

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the A, C, W, and Y serogroups are available. A pentavalent ...

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine compared to the World Health ...